Adoptive cell therapy for Melanoma using tumour infiltrating lymphocytes: John Bridgeman
4 Vues
• 07/30/23
0
0
Intégrer
administrator
Les abonnés
A look at the use of TIL in Melanoma and future TIL engineering strategies. John Bridgeman is the Director of Cell Therapy Research at Immetacyte Ltd
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires